Chapter 8 Flashcards
Azathioprine & Allopurinol
Reduce dose of Azathioprine when given with allopurinol- risk of bone marrow suppression
Azathioprine & mycophenolate Side effect
Red cell aplasia
- dose reduction
- discontinuation
What side effects can happen at early stages of treatment with Azathioprine in RA?
Nausea, vomiting and diarrhoea
If these happen, discontinue
Azathioprine
Monitoring requirements
- FBC for 4 weeks, then every 3 months
- monitor toxicity throughout treatment
- signs of myelosuppression
TPMT activity &
antiproliferative drugs
Tiopurine Methyltransferase (TPMT) activity should be measured before treatment and if it is reduced then patients are at risk of myelosuppression
Mycophenolate
Has more selective mode of action compared to Azathioprine (antiproliferative drugs)
Which ones are antiproliferative drugs? What advice need to be given to patients?
- Azathioprine and Mycophenolate
- Advice - bone marrow suppression
Concurrent administration of immunosuppressants - risk?
- recurrent infection
- respiratory symptoms (cough and dyspnoea)
Pregnancy prevention & Mycophenolate
- exclude pregnancy before and during treatment
- use two effective methods of contraception during treatment and 6 weeks after for women
- and for 90 days after discontinuation for men
Ciclosporin (High risk)
- potent immunosuppressant
- nephrotoxic
- requires loading dose
- prescribe by brand name
Ciclosporin & sunscreen
Advice patient to avoid exposure to UV light (sunlight) and use sunscreen
Monitoring requirements of ciclosporin
- rental function
- liver function
- BP
- FBC
- dermatological and physical examination
- blood lipids
- serum electrolytes (potassium & magnesium)
Ciclosporin contraindications
- must not have live vaccines
- avoid grapefruit juice
- avoid high potassium diet
- oral solutions can be taken with apple or orange juice to improve taste
Ciclosporin interactions
- ciclosporin & statins -> myopathy
- ciclosporin & colchicine -> nephrotoxicity and myotoxicity
- ciclosporin & digoxin -> increased risk of toxicity
- risk of nephrotoxicity +NSAIDs
- increased plasma concentration (clarithromycin, erithromycin, antifungals, metoclopramide, verapamil, & tacrolimus)
- decreases plasma concentration (carbamazepine, orlistat, SJW, phenytoin, phenobarbital, rifampicin)
- risk of hyperkalaemia (ACE, ARBs, aldosterone antagonists